Arbutus Biopharma
ABUS
ABUS
49 hedge funds and large institutions have $65.5M invested in Arbutus Biopharma in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 15 increasing their positions, 10 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
35% less capital invested
Capital invested by funds: $100M → $65.5M (-$34.9M)
Holders
49
Holding in Top 10
–
Calls
$8.69M
Puts
$3.66M
Top Buyers
1 | +$8.93M | |
2 | +$2.65M | |
3 | +$1.44M | |
4 |
Citigroup
New York
|
+$1.34M |
5 |
B
Bailard
Foster City,
California
|
+$1.21M |
Top Sellers
1 | -$7.93M | |
2 | -$6.27M | |
3 | -$2.41M | |
4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$2.11M |
5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.83M |